Platelet-rich fibrin prevents postoperative intestinal adhesion

Jia Wang1, Kai Le2, Xu Guo1

  • 1Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

Insights

Platelet-rich fibrin (PRF) significantly reduced intestinal adhesion in mice by promoting healing and reducing inflammation. This biomaterial shows promise for preventing postoperative adhesions in abdominal surgery.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Surgical Innovation

Background:

  • Postoperative intestinal adhesions are a common complication following abdominal surgery.
  • Adhesions can lead to bowel obstruction, infertility, and chronic pain, necessitating further surgical intervention.
  • Current prevention strategies have limitations, highlighting the need for novel therapeutic approaches.

Purpose of the Study:

  • To investigate the efficacy of platelet-rich fibrin (PRF) in preventing postoperative intestinal adhesions.
  • To evaluate the impact of PRF on the histological characteristics of adhesion formation.
  • To compare PRF with sodium hyaluronate and a no-treatment control in a murine adhesion model.

Main Methods:

  • A murine model of intestinal adhesion was created using abdominal wall defects and cecum damage.
  • PRF was applied to the surgical site in the experimental group.
  • Control groups received sodium hyaluronate or no treatment; all animals were monitored for 28 days.

Main Results:

  • The incidence of intestinal adhesion was significantly lower in the PRF group (35.0%) compared to the control groups (66.7% and 73.7%).
  • Histological analysis revealed reduced fibrosis, fewer fibroblasts and inflammatory cells, and increased mesothelial cells in the PRF group.
  • A dose-dependent correlation was observed, with lower adhesion severity correlating with improved histological markers.

Conclusions:

  • Platelet-rich fibrin demonstrates significant potential in reducing the incidence and severity of postoperative intestinal adhesions.
  • PRF may promote healing by enhancing mesothelial cell proliferation while suppressing fibroblast activity and inflammation.
  • These findings suggest PRF as a promising biomaterial for preventing intra-abdominal adhesions in surgical settings.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
990
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
12.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.4K